Ohr announces $14.175 million public offering

Ohr Pharmaceutical will offer common stock and warrants in a public offering, the company announced in a press release. The $14.175 million public offering will be priced at $0.70 per share of common stock. Accompanying warrants to purchase 0.7 of a share of common stock will have an exercise price of $1.

Full Story →